Ann & Robert H. Lurie Children's Hospital of Chicago: Novel Drug Shows Promise for Inherited Blood Disorder
May 01, 2020
May 01, 2020
CHICAGO, Illinois, May 1 -- The Ann and Robert H. Lurie Children's Hospital issued the following news release:
A novel drug called luspatercept has shown to reduce the need for blood transfusions in patients with an inherited blood disorder called transfusion-dependent beta-thalassemia.
The findings, published in the New England Journal of Medicine, shed light on the potential for disease modifying therapies helping patients with severe cases of the disease who req . . .
A novel drug called luspatercept has shown to reduce the need for blood transfusions in patients with an inherited blood disorder called transfusion-dependent beta-thalassemia.
The findings, published in the New England Journal of Medicine, shed light on the potential for disease modifying therapies helping patients with severe cases of the disease who req . . .